By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Breaking US News – USA Business MediaBreaking US News – USA Business MediaBreaking US News – USA Business Media
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Font ResizerAa
Breaking US News – USA Business MediaBreaking US News – USA Business Media
Font ResizerAa
  • Home
  • USA
  • World
  • Business
  • Health
  • Sports
  • Cryptocurrency
  • Entertainment
  • Technology
Search
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Follow US
Home » Blog » Reliance Q4 net rises to ₹19,407 cr; revenue beats estimates at ₹2.65 lakh cr
Business

Reliance Q4 net rises to ₹19,407 cr; revenue beats estimates at ₹2.65 lakh cr

Olivia Roberts
By Olivia Roberts
Share
1 Min Read
SHARE

    Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, marking an interannual increase of 2.4%.

Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, marking an interannual increase of 2.4%. | Photo credit: given Ruvic/Reuters

Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, 2.4% more interannual, while revenues increased 10% to ₹ 2.65 Lakh Crore, overcoming estimates.

Topline growth was driven by its dominant oil to chemical business, together with an increase in retail income and digital services.

The company has recommended a dividend of ₹ 5.50 per action and approved the collection of up to ₹ 25000 million rupees through the issuance of non -convertible obligations.

Posted on April 25, 2025

Share This Article
Facebook Copy Link Print

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Rahul Yadav Indian Entrepreneur | India’s Mastermind of IT Innovation

In a time when technology reshapes every aspect of life and business,…

Apple’s ‘Friday Night Baseball’ is back on March 28 with a World Series documentary in tow

Apple's offered Major League Baseball games through the Apple TV app since…

10 Benefits of Forex Hedging Most Traders Don’t Know About

Hedging is possibly the most misunderstood trading method in the world. It's…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Business

Suzlon Energy shares dip 1.11% amid market volatility despite recent gains

By Olivia Roberts
Business

Purpose-driven funding at inception – The Hindu BusinessLine

By Olivia Roberts
Business

Day Trading Guide for April 25, 2025: Intraday supports, resistances for Nifty50 stocks

By Olivia Roberts
Business

Deutsche Bank observes Chinese clients moving out of US assets

By Olivia Roberts
Breaking US News – USA Business Media
USA
  • USA
  • World
  • Technology
  • Cryptocurrency
Business
  • CEO
  • Founder
  • Journalist
  • Entrepreneur
  • Technology
Health
  • Doctor
  • Beauty Cosmetics
  • Plastic Surgeon
Sports
  • Coach
  • Fitness Trainer
  • Entertainment

© 2017-2025 usabusinessmedia. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?